Humana Inc vs Snap On Incorporated — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Snap On Incorporated trades at $360.27 (market cap $18.62B). The key difference: Humana Inc is far larger — about 2.6× Snap On Incorporated's market cap, and Snap On Incorporated pays the higher dividend (2.71%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Snap On Incorporated for 36 Days on average.
| HUM | SNA | |
|---|---|---|
Market Cap | $47.61B | $18.62B |
Volume | 1,827,332 | 360,121 |
Sector | Health | Industrials |
52-Week High | $409.85 | $419.31 |
52-Week Low | $163.67 | $327.33 |
Typical Hold Time | 53 Days | 36 Days |
Enterprise Value | $54.97B | $18.25B |
Dividend Yield | 0.89% | 2.71% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Snap-on Incorporated (SNA) trades at $359.89, down 2.37% on the day, with a bearish technical signal from moving averages and oscillators. Fundamentally, the company maintains strong profitability with a 19.6% net income margin and a 17.58% ROE, though Q1 2026 earnings slightly missed expectations. Recent news highlights gross margin expansion and institutional position adjustments.
The outlook is supported by analyst consensus with a $449 price target and 66.7% buy ratings, but risks include valuation premiums and mixed segment trends. Earnings growth from innovation and RCI initiatives remains a key catalyst, though integration costs and softer OEM demand pose execution risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →